Bokhari Raza 4

What Happened
Bokhari Raza, CEO of Medicus Pharma Ltd. (MDCX), was granted an award of 500,000 derivative shares (an option/award) on June 3, 2026. The filing shows an acquisition at $0.00 per share (no cash paid at grant); the transaction is recorded as a derivative award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-03; Form 4 filed 2026-06-04 (timely filing).
• Instrument: Award/option (derivative) for 500,000 shares, reported acquisition price $0.00.
• Reported cash value on the form: $0 (award/derivative grant).
• Vesting: The option vests quarterly in four equal installments over one year (footnote F1).
• Shares owned after transaction: Not specified in the summary data provided.
• Filing status: Not indicated as late (Period of Report 2026-06-03; filing next day).

Context
This was a compensation-related option grant (derivative award) that vests over the coming year; it does not represent an immediate market purchase or sale. Such grants are common for executive compensation and do not by themselves indicate that the insider bought or sold company stock.